Nuclear factor ?B predicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor. (2012)
Attributed to:
Alignment of Synthesis, Medicinal Chemistry and Structural Genomics to Accelerate UK Drug Discovery: Network SMS-Drug
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.humpath.2011.11.009
PubMed Identifier: 22406367
Publication URI: http://europepmc.org/abstract/MED/22406367
Type: Journal Article/Review
Volume: 43
Parent Publication: Human pathology
Issue: 9
ISSN: 0046-8177